Co-diagnostics share price today

(CODX)

Co-diagnostics share price is $0.73 & ₹62.03 as on 21 Dec 2024, 2.30 'hrs' IST

$0.73

Market is closed - opens 8 PM, 23 Dec 2024

View live Co-diagnostics share price in Dollar and Rupees. Guide to invest in Co-diagnostics from India. Also see the sentimental analysis on Indian investors investing in Co-diagnostics. Get details on the Indian mutual funds that are investing in Co-diagnostics. Get Analyst recommendations and forecasts along with all the Co-diagnostics's financials.

Co-diagnostics share price movements

Today's Low: $0.72
Today's High: $0.77
$0.73
1.23%
Downside
Day's Volatility :5.75%
Upside
4.58%
52 Weeks Low: $0.70
52 Weeks High: $2.23
$0.73
4.11%
Downside
52 Weeks Volatility :68.61%
Upside
67.26%

Co-diagnostics Returns

Period	Co-diagnostics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-39.67%	-11.1%	0.0%
6 Months	-47.48%	-6.0%	0.0%
1 Year	-36.52%	2.7%	0.0%
3 Years	-92.4%	0.6%	-19.7%

Co-diagnostics Key Statistics

in dollars & INR

Previous Close	$0.7252
Open	$0.73
Today's High	$0.765
Today's Low	$0.721
Market Capitalization	$23.2M
Today's Volume	$141.3K
52 Week High	$2.2299
52 Week Low	$0.7
Revenue TTM	$7.3M
EBITDA	$-38.7M
Earnings Per Share (EPS)	$-1.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.31%
Return On Equity TTM	-50.57%

How to invest in Co-diagnostics from India?

It is very easy for Indian residents to invest directly in Co-diagnostics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Co-diagnostics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Co-diagnostics or CODX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Co-diagnostics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Co-diagnostics shares which would translate to 1.164 fractional shares of Co-diagnostics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Co-diagnostics, in just a few clicks!

Returns in Co-diagnostics for Indian investors in Rupees

Investment Value

₹1,00,000

Co-diagnostics investment value today

Current value as on today

₹1,38,718

Returns

₹38,718

(+38.72%)

Returns from Co-diagnostics Stock

₹36,522 (false-36.52%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Co-diagnostics

103%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Co-diagnostics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 103% more investors are searching Co-diagnostics in the last 30 days versus the previous period.

Global Institutional Holdings in Co-diagnostics

Vanguard Group Inc
5.58%
Renaissance Technologies Corp
1.78%
BlackRock Inc
1.57%
Geode Capital Management, LLC
1.01%
Bridgeway Capital Management, LLC
0.85%
Susquehanna International Group, LLP
0.59%

Analyst Recommendation on Co-diagnostics

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Co-diagnostics(by analysts ranked 0 to 5 stars)

Based on 6 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Co-diagnostics

What analysts predicted

Upside of 105.48%

Current:

$0.73

Target:

$1.50

Insights on Co-diagnostics

Price Movement
In the last 7 days, CODX stock has moved down by -12.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 161.10K → 641.14K (in $), with an average increase of 74.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -7.59M → -9.69M (in $), with an average decrease of 27.6% per quarter
CODX vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 99.5%
CODX vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 208.3%
Price to Sales
ForCODX every $1 of sales, investors are willing to pay $3.0, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Co-diagnostics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$39.9K	↑ 420.9%
Net Income	$-6.3M	↓ 9.88%
Net Profit Margin	-15.7K%	↑ 75113.61%

	FY19	Y/Y Change
Revenue	$215.0K	↑ 438.63%
Net Income	$-6.1M	↓ 3.23%
Net Profit Margin	-2.8K%	↑ 12891.09%

	FY20	Y/Y Change
Revenue	$74.6M	↑ 34579.9%
Net Income	$42.5M	↓ 799.91%
Net Profit Margin	56.98%	↑ 2880.16%

	FY21	Y/Y Change
Revenue	$97.9M	↑ 31.3%
Net Income	$36.7M	↓ 13.7%
Net Profit Margin	37.45%	↓ 19.53%

	FY22	Y/Y Change
Revenue	$34.2M	↓ 65.04%
Net Income	$-14.2M	↓ 138.84%
Net Profit Margin	-41.61%	↓ 79.06%

	FY23	Y/Y Change
Revenue	$6.8M	↓ 80.09%
Net Income	$-35.3M	↑ 148.15%
Net Profit Margin	-518.68%	↓ 477.07%

	Q2 FY23	Q/Q Change
Revenue	$197.8K	↓ 67.14%
Net Income	$-8.9M	↑ 54.96%
Net Profit Margin	-4.5K%	↓ 3552.76%

	Q3 FY23	Q/Q Change
Revenue	$2.5M	↑ 1142.18%
Net Income	$-6.0M	↓ 32.93%
Net Profit Margin	-243.47%	↑ 4265.4%

	Q4 FY23	Q/Q Change
Revenue	$3.6M	↑ 44.69%
Net Income	$-14.7M	↑ 145.34%
Net Profit Margin	-412.82%	↓ 169.35%

	Q1 FY24	Q/Q Change
Revenue	$252.7K	↓ 92.89%
Net Income	$-9.3M	↓ 36.55%
Net Profit Margin	-3.7K%	↓ 3271.54%

	Q2 FY24	Q/Q Change
Revenue	$161.1K	↓ 36.26%
Net Income	$-7.6M	↓ 18.39%
Net Profit Margin	-4.7K%	↓ 1032.72%

	Q3 FY24	Q/Q Change
Revenue	$641.1K	↑ 297.97%
Net Income	$-9.7M	↑ 27.6%
Net Profit Margin	-1.5K%	↑ 3204.71%

	FY18	Y/Y Change
Profit	$30.5K	↑ 314.67%

	FY19	Y/Y Change
Profit	$102.5K	↑ 235.99%

	FY20	Y/Y Change
Profit	$58.0M	↑ 56424.01%

	FY21	Y/Y Change
Profit	$86.3M	↑ 48.91%

	FY22	Y/Y Change
Profit	$28.7M	↓ 66.71%

	FY23	Y/Y Change
Profit	$2.6M	↓ 90.86%

	Q2 FY23	Q/Q Change
Profit	$-261.3K	↓ 362.03%

	Q3 FY23	Q/Q Change
Profit	$2.2M	↓ 942.49%

	Q4 FY23	Q/Q Change
Profit	$274.5K	↓ 87.53%

	Q1 FY24	Q/Q Change
Profit	$-312.3K	↓ 213.8%

	Q2 FY24	Q/Q Change
Profit	$-389.4K	↑ 24.67%

	Q3 FY24	Q/Q Change
Profit	$343.7K	↓ 188.28%

	FY18	Y/Y Change
Operating Cash Flow	$-4.1M	↑ 27.05%
Investing Cash Flow	$-380.3K	↑ 100.91%
Financing Cash Flow	$1.9M	↓ 68.4%

	FY19	Y/Y Change
Operating Cash Flow	$-5.5M	↑ 35.42%
Investing Cash Flow	$-435.2K	↑ 14.44%
Financing Cash Flow	$5.9M	↑ 214.65%

	FY20	Y/Y Change
Operating Cash Flow	$28.2M	↓ 609.77%
Investing Cash Flow	$-5.8M	↑ 1238.17%
Financing Cash Flow	$19.7M	↑ 234.44%

	FY21	Y/Y Change
Operating Cash Flow	$41.1M	↑ 45.86%
Investing Cash Flow	$4.1M	↓ 170.37%
Financing Cash Flow	$450.4K	↓ 97.72%

	FY22	Y/Y Change
Operating Cash Flow	$6.6M	↓ 84.01%
Investing Cash Flow	$-58.2M	↓ 1519.19%
Financing Cash Flow	$-14.0M	↓ 3215.91%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-5.2M	↓ 5.27%
Investing Cash Flow	$13.2M	↓ 224.49%
Financing Cash Flow	$-555.7K	↑ 15.25%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-6.6M	↑ 26.59%
Investing Cash Flow	$3.2M	↓ 76.05%
Financing Cash Flow	$-166.3K	↓ 70.07%

Co-diagnostics Technicals Summary

Sell

Neutral

Buy

Co-diagnostics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Co-diagnostics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Co-diagnostics Inc	-31.13%	-47.48%	-36.52%	-92.4%	-24.36%
Stryker Corporation	-6.55%	7.53%	22.55%	38.08%	71.54%
Boston Scientific Corp.	-2.79%	15.96%	59.12%	110.98%	96.7%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.35%	-41.48%	-5.43%
Abbott Laboratories	-2.58%	8.48%	4.77%	-17.81%	30.77%
Medtronic Plc	-4.38%	-0.01%	-1.09%	-20.04%	-28.85%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Co-diagnostics Inc	4.96	NA	0.0	0.0	-0.51	-0.28	NA	2.0
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Co-diagnostics Inc	Sell	$23.2M	-24.36%	4.96	0.0%
Stryker Corporation	Buy	$136.1B	71.54%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.7%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-5.43%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.77%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.85%	24.46	12.06%

About Co-diagnostics

co-diagnostics, inc. is a molecular diagnostics company that has acquired certain unique, patented diagnostic testing technology. a utah corporation headquartered in sandy, utah, its primary business is to commercialize its unique, patented technology through sales, development and licensing. the technology is embodied in three patent applications and certain trade secrets, which make dna testing for diseases faster, higher in performance, and more cost efficient than traditional technologies of the past. the company has undertaken completely innovative approaches to develop novel molecular technologies using biophysical models and statistical bioinformatics. it has successfully developed and commercialized a series of assays in the infectious disease area to demonstrate the capability of its technology. the technology on which the inventions are based were created by reference to certain mathematical models invented, designed and refined by dr. brent c. satterfield. the inventions are

Organization	Co-diagnostics
Employees	155
CEO	Mr. Dwight H. Egan
Industry	Health Technology

Management People of Co-diagnostics

Name	Title
Mr. Dwight H. Egan	Chairman & CEO
Mr. Brian L. Brown CPA	CFO & Company Secretary
Mr. Richard David Abbott	President
Dr. Brent C. Satterfield Ph.D.	Co-Founder & Member of Scientific Advisory Board
Mr. David Nielsen	Chief Operating Officer
Mr. Dan Bohrer CPA	Vice President of Finance & Accounting
Mr. Christopher Thurston	Chief Technology Officer
Mr. Andrew Benson	Head of Investor Relations
Dr. Mayuranki Almaula	Senior Vice President of Overseas Operations & Strategic Alliances
Mr. Cameron Gundry	Head of Commercialization LATAM/EUR

Important FAQs about investing in Co-diagnostics from India :

What is Co-diagnostics share price today?

Co-diagnostics share price today stands at $0.73, Open: $0.73 ; Previous Close: $0.73 ; High: $0.77 ; Low: $0.72 ; 52 Week High: $2.23 ; 52 Week Low: $0.70. The stock opens at $0.73, after a previous close of $0.73. The stock reached a daily high of $0.77 and a low of $0.72, with a 52-week high of $2.23 and a 52-week low of $0.70.

Can Indians buy Co-diagnostics shares?

Yes, Indians can invest in the Co-diagnostics (CODX) from India.

With INDmoney, you can buy Co-diagnostics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Co-diagnostics at zero transaction cost.

How can I buy Co-diagnostics shares from India?

It is very easy to buy Co-diagnostics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Co-diagnostics be purchased?

Yes, you can buy fractional shares of Co-diagnostics with INDmoney app.

What are the documents required to start investing in Co-diagnostics stocks?

To start investing in Co-diagnostics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.